Inhibition of innate immune responses to tumours by CD4+CD25+ regulatory T cells

Inhibition of innate immune responses to tumours by CD4+CD25+ regulatory T cells

Bibliographische Detailangaben
Hauptverfasser:	Richards, H, Simon, A, Jones, E, Williams, A, Screaton, G, Gallimore, A
Format:	Journal article
Veröffentlicht:	2005

Ähnliche Einträge

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.
von: Simon, A, et al.
Veröffentlicht: (2007)

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity
von: Simon, A, et al.
Veröffentlicht: (2007)

The influence of CD25+ cells on the generation of immunity to tumour cell lines in mice.
von: Jones, E, et al.
Veröffentlicht: (2004)

The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen.
von: Bushell, A, et al.
Veröffentlicht: (2005)

Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells.
von: Maloy, K, et al.
Veröffentlicht: (2005)

Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens.
von: Golgher, D, et al.
Veröffentlicht: (2002)

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.
von: Sarah L Clarke, et al.
Veröffentlicht: (2006-12-01)

Positive and negative influences of regulatory T cells on tumour immunity.
von: Gallimore, A, et al.
Veröffentlicht: (2008)

Depletion of CD25+ regulatory cells results in suppression of melanomagrowth and induction of autoreactivity in mice
von: Jones, E, et al.
Veröffentlicht: (2002)

Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice.
von: Jones, E, et al.
Veröffentlicht: (2002)

Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in a murine mammary breast cancer model.
von: Hong, H, et al.
Veröffentlicht: (2010)

Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell‐mediated anti‐tumour immunity in a murine mammary breast cancer model
von: Hong, H, et al.
Veröffentlicht: (2009)

Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance.
von: Graca, L, et al.
Veröffentlicht: (2002)

CD4+CD25+ T regulatory cells in renal transplantation
von: Jason Cheung, et al.
Veröffentlicht: (2022-11-01)

CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.
von: Maloy, K, et al.
Veröffentlicht: (2003)

Human CD4+CD25+ regulatory T cells are sensitive to low dose cyclophosphamide: implications for the immune response.
von: Daniel Heylmann, et al.
Veröffentlicht: (2013-01-01)

Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity.
von: Shuang Zhou, et al.
Veröffentlicht: (2013-01-01)

Proteomic characterization of murine CD4(+)CD25(+) regulatory T cells
von: Rovis, F, et al.
Veröffentlicht: (2004)

Phenotypic characterization of regulatory CD4+CD25+ T cells in rats.
von: Stephens, L, et al.
Veröffentlicht: (2004)

Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo.
von: Read, S, et al.
Veröffentlicht: (2006)

Downregulation of CD4+LAP+ and CD4+CD25+ Regulatory T Cells in Acute Coronary Syndromes
von: Ying-zhong Lin, et al.
Veröffentlicht: (2013-01-01)

Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process.
von: Karim, M, et al.
Veröffentlicht: (2004)

Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection.
von: Lühn, K, et al.
Veröffentlicht: (2007)

Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection.
von: Lühn, K, et al.
Veröffentlicht: (2007)

T-cell receptor repertoire usage after allografting differs between CD4+CD25+ regulatory T cells and their CD4+CD25− counterpart
von: Claudio Fozza, et al.
Veröffentlicht: (2007-02-01)

Correction: Depletion of CD4+ CD25+ Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity
Veröffentlicht: (2014-01-01)

Correction: Depletion of CD4 CD25 Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity.
Veröffentlicht: (2014-01-01)

Indirubin Increases CD4+CD25+Foxp3+ Regulatory T Cells to Prevent Immune Thrombocytopenia in Mice.
von: Aijun Zhang, et al.
Veröffentlicht: (2015-01-01)

Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.
von: Mottet, C, et al.
Veröffentlicht: (2003)

Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells
von: Eleonora Tresoldi, et al.
Veröffentlicht: (2011-09-01)

Altered Frequencies of CD4+ CD25+ Foxp3+ and CD8+ CD25+ Foxp3+ Regulatory T Cells in Pre-eclampsia
von: Maryam Zare, et al.
Veröffentlicht: (2018-12-01)

HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
von: Julian Wachstein, et al.
Veröffentlicht: (2012-01-01)

CD4+CD25+ and CD4+CD25high regulatory T cells in disseminated and localized forms of allergic contact dermatitis: relation to specific cytokines
von: Teresa Reduta, et al.
Veröffentlicht: (2011-07-01)

Impaired Ca²⁺ regulation of CD4⁺CD25⁺ regulatory T cells from pediatric asthma.
von: Yamamoto, Y, et al.
Veröffentlicht: (2011)

Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells.
von: Lim, H, et al.
Veröffentlicht: (2005)

CD4+CD25highCD127- regulatory T-cells in COPD: smoke and drugs effect
von: Alessandra Chiappori, et al.
Veröffentlicht: (2016-01-01)

CD4+CD25high Regulatory T Cells in the Developing Human Immune System: Implications for Pediatric HIV Infection
von: McCune Joseph M, et al.
Veröffentlicht: (2005-12-01)

Alteration in Frequency and Function of CD4+CD25+ FOXP3+ Regulatory T cells in Patients with Immune Thrombocytopenic Purpura
von: Nargess Arandi, et al.
Veröffentlicht: (2014-04-01)

Therapy with CD4+CD25+ T regulatory cells – should we be afraid of cancer?
von: Mateusz Gliwiński, et al.
Veröffentlicht: (2019-04-01)

Regulatory T-cells CD4+CD25+Foxр3+ in patients with remitting multiple sclerosis
von: D. D. Eliseeva, et al.
Veröffentlicht: (2017-02-01)